These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

392 related items for PubMed ID: 20574447

  • 1. The prevalence of metabolic syndrome and its components in two main types of primary aldosteronism.
    Somlóová Z, Widimský J, Rosa J, Wichterle D, Strauch B, Petrák O, Zelinka T, Vlková J, Masek M, Dvoráková J, Holaj R.
    J Hum Hypertens; 2010 Oct; 24(10):625-30. PubMed ID: 20574447
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The role of biochemical tests and clinical symptoms in differential diagnosis of primary aldosteronism.
    Prejbisz A, Postuła M, Cybulska I, Dobrucki T, Kabat M, Peczkowska M, Janas J, Janaszek-Sitkowska H, Makowiecka-Cieśla M, Januszkiewicz A.
    Kardiol Pol; 2003 Jan; 58(1):17-26. PubMed ID: 14502298
    [Abstract] [Full Text] [Related]

  • 4. Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study.
    Giacchetti G, Ronconi V, Turchi F, Agostinelli L, Mantero F, Rilli S, Boscaro M.
    J Hypertens; 2007 Jan; 25(1):177-86. PubMed ID: 17143190
    [Abstract] [Full Text] [Related]

  • 5. Metabolic syndrome in primary aldosteronism and essential hypertension: relationship to adiponectin gene variants.
    Ronconi V, Turchi F, Rilli S, Di Mattia D, Agostinelli L, Boscaro M, Giacchetti G.
    Nutr Metab Cardiovasc Dis; 2010 Feb; 20(2):93-100. PubMed ID: 19481913
    [Abstract] [Full Text] [Related]

  • 6. Prospective evaluation of the saline infusion test for excluding primary aldosteronism due to aldosterone-producing adenoma.
    Rossi GP, Belfiore A, Bernini G, Desideri G, Fabris B, Ferri C, Giacchetti G, Letizia C, Maccario M, Mallamaci F, Mannelli M, Montemurro D, Palumbo G, Rizzoni D, Rossi E, Semplicini A, Agabiti-Rosei E, Pessina AC, Mantero F, PAPY Study Investigators.
    J Hypertens; 2007 Jul; 25(7):1433-42. PubMed ID: 17563566
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Clinical characteristics of aldosterone-producing microadenoma, macroadenoma, and idiopathic hyperaldosteronism in 93 patients with primary aldosteronism.
    Omura M, Sasano H, Saito J, Yamaguchi K, Kakuta Y, Nishikawa T.
    Hypertens Res; 2006 Nov; 29(11):883-9. PubMed ID: 17345788
    [Abstract] [Full Text] [Related]

  • 9. Verification and evaluation of aldosteronism demographics in the Taiwan Primary Aldosteronism Investigation Group (TAIPAI Group).
    Kuo CC, Wu VC, Huang KH, Wang SM, Chang CC, Lu CC, Yang WS, Tsai CW, Lai CF, Lee TY, Lin WC, Wu MS, Lin YH, Chu TS, Lin CY, Chang HW, Wang WJ, Kao TW, Chueh SC, Wu KD, Taipai Study Group.
    J Renin Angiotensin Aldosterone Syst; 2011 Sep; 12(3):348-57. PubMed ID: 21393359
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Primary aldosteronism -- screening, diagnosis and therapy.
    Horký K, Gregorová I, Vancura J, Silinková-Málková E, Hradec E.
    Cor Vasa; 1981 Sep; 23(4):265-79. PubMed ID: 7028394
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Have main types of primary aldosteronism different phenotype?
    Somlóová Z, Indra T, Rosa J, Petrák O, Strauch B, Zelinka T, Holaj R, Widimský J.
    Physiol Res; 2012 Sep; 61(4):431-6. PubMed ID: 22670702
    [Abstract] [Full Text] [Related]

  • 14. The syndromes of low-renin hypertension: "separating the wheat from the chaff".
    Kater CE, Biglieri EG.
    Arq Bras Endocrinol Metabol; 2004 Oct; 48(5):674-81. PubMed ID: 15761538
    [Abstract] [Full Text] [Related]

  • 15. Primary aldosteronism: renaissance of a syndrome.
    Young WF.
    Clin Endocrinol (Oxf); 2007 May; 66(5):607-18. PubMed ID: 17492946
    [Abstract] [Full Text] [Related]

  • 16. Decreased plasma prorenin levels in primary aldosteronism: potential diagnostic implications.
    Berge C, Courand PY, Harbaoui B, Paget V, Khettab F, Bricca G, Fauvel JP, Lantelme P.
    J Hypertens; 2015 Jan; 33(1):118-25. PubMed ID: 25333683
    [Abstract] [Full Text] [Related]

  • 17. Nocturnal, daytime, and postural changes of plasma aldosterone before and during dexamethasone in adenomatous and idiopathic aldosteronism.
    Hoefnagels WH, Drayer JI, Smals AG, Benraad TJ, Kloppenborg PW.
    J Clin Endocrinol Metab; 1980 Dec; 51(6):1330-4. PubMed ID: 7440698
    [Abstract] [Full Text] [Related]

  • 18. Detecting and treating primary aldosteronism: primary aldosteronism.
    Mantero F, Mattarello MJ, Albiger NM.
    Exp Clin Endocrinol Diabetes; 2007 Mar; 115(3):171-4. PubMed ID: 17427105
    [Abstract] [Full Text] [Related]

  • 19. Primary aldosteronism and essential hypertension: assessment of cardiovascular risk at diagnosis and after treatment.
    Turchi F, Ronconi V, di Tizio V, Ceccoli L, Boscaro M, Giacchetti G.
    Nutr Metab Cardiovasc Dis; 2014 May; 24(5):476-82. PubMed ID: 24630976
    [Abstract] [Full Text] [Related]

  • 20. Elevation of angiotensin-II type-1-receptor autoantibodies titer in primary aldosteronism as a result of aldosterone-producing adenoma.
    Rossitto G, Regolisti G, Rossi E, Negro A, Nicoli D, Casali B, Toniato A, Caroccia B, Seccia TM, Walther T, Rossi GP.
    Hypertension; 2013 Feb; 61(2):526-33. PubMed ID: 23248149
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.